PMID: 2505990Sep 1, 1989Paper

Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide

Diabetes Care
V TrischittaR Vigneri

Abstract

Secondary failure to oral hypoglycemic agents (OHAs) is a possible outcome for non-insulin-dependent diabetes mellitus (NIDDM) patients and poses a serious therapeutic problem. In this study, we evaluated the effect of adding a single bedtime low-dose NPH insulin injection to the previous ineffective sulfonylurea therapy in 23 NIDDM patients with true secondary failure to OHAs. This treatment schedule was conducted for 3 mo by 18 patients (78%) who completed the study. In these patients, the addition of NPH insulin (0.2 +/- 0.01 IU/kg body wt) greatly decreased fasting and postprandial plasma glucose (P less than .001) and glycosylated hemoglobin (P less than .005). No weight gain was observed in any of the patients studied. Five patients dropped out: 2 patients (9%) due to insufficient compliance, 2 patients (9%) due to the multiple insulin injections required to achieve good metabolic control, and 1 patient (4%) due to recurrent hypoglycemic episodes. No correlation was observed between glucagon-stimulated C-peptide values and amelioration of metabolic control. In conclusion, most NIDDM patients with secondary failure to OHAs may be successfully treated with the addition of a single low-dose bedtime NPH insulin injection, and...Continue Reading

Citations

Nov 26, 2003·Clinics in Podiatric Medicine and Surgery·James BerneneGary Peter Jolly
Mar 1, 1992·Journal of Internal Medicine·T SaneM R Taskinen
Feb 1, 1990·Australian and New Zealand Journal of Ophthalmology·C P White, M J Hooper
Nov 1, 1992·Diabetic Medicine : a Journal of the British Diabetic Association·D E SeiglerJ S Skyler
Feb 1, 1991·Annals of Medicine·T SaneM Välimäki
Mar 1, 1992·The American Journal of the Medical Sciences·M RiddleP McDaniel
Jan 1, 1991·Diabetes Research and Clinical Practice·M C Riddle
Oct 21, 2003·The Annals of Pharmacotherapy·Mary U Kabadi, Udaya M Kabadi
Feb 1, 1993·The Annals of Pharmacotherapy·C E RaeD D Cook

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.